TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH HEMATOPOIETIC GROWTH-FACTORS

[61] JANOWSKAWIECZOREK A, 1991, BLOOD, V77, P1796

[62] JANSSEN JWG, 1989, BLOOD, V73, P248

[63] KARP JE, 1990, LEUKEMIA, V4, P553

[64] NATURAL-KILLER CELL-MEDIATED INHIBITION OF BONE-MARROW COLONY FORMATION (CFU-GM) IN REFRACTORY-ANEMIA (PRELEUKEMIA) - EVIDENCE FOR PATIENT-SPECIFIC CELL-POPULATIONS [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (04) : 457 - 462

[65] TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR - A PRELIMINARY-REPORT [J]. AMERICAN JOURNAL OF MEDICINE, 1989, 86 (02) : 178 - 182

[66] DIFFERENTIAL DOSE-RELATED HEMATOLOGICAL EFFECTS OF GM-CSF IN PANCYTOPENIA - EVIDENCE SUPPORTING THE ADVANTAGE OF LOW-DOSE OVER HIGH-DOSE ADMINISTRATION IN SELECTED PATIENTS [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1991, 78 (03) : 352 - 358

[67] PHASE-I STUDY OF RECOMBINANT HUMAN INTERLEUKIN-3 IN PATIENTS WITH BONE-MARROW FAILURE [J]. JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (07) : 1241 - 1250

[68] Lindemann A, 1991, Eur Cytokine Netw, V2, P173

[69] THE MYELODYSPLASTIC SYNDROMES - BIOLOGY AND IMPLICATIONS FOR MANAGEMENT [J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (08) : 1424 - 1441

[70] GENERATION OF CYTOTOXIC NK CELLS IN PERIPHERAL-BLOOD AND BONE-MARROW OF PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA AFTER CONTINUOUS INFUSION WITH RECOMBINANT INTERLEUKIN-2 [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1991, 37 (02) : 88 - 99

[61] JANOWSKAWIECZOREK A, 1991, BLOOD, V77, P1796

[62] JANSSEN JWG, 1989, BLOOD, V73, P248

[63] KARP JE, 1990, LEUKEMIA, V4, P553

[64] NATURAL-KILLER CELL-MEDIATED INHIBITION OF BONE-MARROW COLONY FORMATION (CFU-GM) IN REFRACTORY-ANEMIA (PRELEUKEMIA) - EVIDENCE FOR PATIENT-SPECIFIC CELL-POPULATIONS [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (04) : 457 - 462

[65] TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR - A PRELIMINARY-REPORT [J]. AMERICAN JOURNAL OF MEDICINE, 1989, 86 (02) : 178 - 182

[66] DIFFERENTIAL DOSE-RELATED HEMATOLOGICAL EFFECTS OF GM-CSF IN PANCYTOPENIA - EVIDENCE SUPPORTING THE ADVANTAGE OF LOW-DOSE OVER HIGH-DOSE ADMINISTRATION IN SELECTED PATIENTS [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1991, 78 (03) : 352 - 358

[67] PHASE-I STUDY OF RECOMBINANT HUMAN INTERLEUKIN-3 IN PATIENTS WITH BONE-MARROW FAILURE [J]. JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (07) : 1241 - 1250

[68] Lindemann A, 1991, Eur Cytokine Netw, V2, P173

[69] THE MYELODYSPLASTIC SYNDROMES - BIOLOGY AND IMPLICATIONS FOR MANAGEMENT [J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (08) : 1424 - 1441

[70] GENERATION OF CYTOTOXIC NK CELLS IN PERIPHERAL-BLOOD AND BONE-MARROW OF PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA AFTER CONTINUOUS INFUSION WITH RECOMBINANT INTERLEUKIN-2 [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1991, 37 (02) : 88 - 99